Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity
ACS Nano · 25.02.2025 · 19 (7) · 7213-7230
DOI: 10.1021/acsnano.4c16981 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.02.2025. Verfasst von Xueqing Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huaxi MR Research Center (HMRRC), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 61004…. Hauptthemen laut MEDLINE: Ferroptosis, Lipid Metabolism, Immunity, Innate, Prostatic Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, China Postdoctoral Science Foundation, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Castration-resistant prostate cancer (CRPC) is an intractable disease, but approaches for eradicating primary tumors and inhibiting metastasis are limited. Considering that lipid metabolism plays key roles in ferroptosis and tumor progression and treatment resistance, here we developed a biomimetic nanovesicle (FiFe@RBM) encapsulating fatty acid synthetase inhibitors and iron oxide nanoparticles for synergistic therapy of CRPC and inhibiting the metastasis. FiFe@RBM with superior magnetic properties efficiently delivered drugs into the CRPC cancer cells, where it can release Fe ions to efficiently induce reactive oxygen species and mitochondrial dysfunction and inhibit the AKT-mTOR pathway, which synergistically causes apoptosis and enhances ferroptosis by rewired lipid metabolism through increasing polyunsaturated fatty acids (PUFAs), PUFA-enriched phosphatidylcholine (PUFA-PC), PUFA-enriched phosphatidylethanolamine (PUFA-PE), etc. By intravenous injection, the high accumulation of FiFe@RBM in PC-3 tumors enabled precision T1/T2-weighted magnetic resonance imaging-guided effective eradication of human CRPC PC-3 tumors by synergistic magnetic hyperthermia therapy (MHT) and ferroptosis, which further inhibited liver metastasis by the activated and recruited high rates of natural killer cells in the nude mice model. This work presents an effective nanovesicle strategy for reprogramming lipid metabolism to enhance ferroptosis in synergy with MHT for effectively treating refractory cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Huaxi MR Research Center (HMRRC), State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
- Department of Ultrasound, Sichuan Cancer Hospital, Chengdu 610042, Sichuan, China.
- Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of C…
- Department of Radiology, Sanya People's Hospital, Sanya 572032, Hainan, China.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Förderung
- West China Hospital, Sichuan University
- China Postdoctoral Science Foundation
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
Zitieren
APA
Cheng, X., Xu, J., Cui, Y., Liu, J., Chen, Y., He, C., Cui, L., Liu, Y., Song, B., Gong, C., & Mi, P. (2025). Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity. ACS Nano, 19(7), 7213-7230. https://doi.org/10.1021/acsnano.4c16981
Vancouver
Cheng X, Xu J, Cui Y, Liu J, Chen Y, He C, et al. Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity. ACS Nano. 2025;19(7):7213-7230. doi:10.1021/acsnano.4c16981
BibTeX
@article{Cheng2025,
author = {Cheng, Xueqing and Xu, Jinshun and Cui, Yongsheng and Liu, Jing and Chen, Yuntian and He, Chuanshi and Cui, Lele and Liu, Yiyao and Song, Bin and Gong, Changyang and Mi, Peng},
title = {Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {7},
pages = {7213--7230},
doi = {10.1021/acsnano.4c16981}
}
EUVIMED